Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001167557-26-000036·AQR CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
Haemonetics Corp
Common stock, $.01 par value per share · CUSIP: 405024100
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AQR Capital Management, LLC
Shares: 3,163,104 · Class: 6.76%
- AQR Capital Management Holdings, LLC
Shares: 3,163,104 · Class: 6.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001167557-26-000036
- Form type
- SCHEDULE 13G
- Filer
- AQR CAPITAL MANAGEMENT LLC
- CIK
- CIK 1167557
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership